secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001437749-23-016136
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq non-compliance notice for late filings; plan due June 20
--------------------------------------------------------------------------------

- Nasdaq notified BIO-key on May 23, 2023 of non-compliance for failing to timely file Form 10-Q for Q1 2023.
- Company was already delinquent on Form 10-K for year ended Dec 31, 2022.
- Must submit compliance plan by June 20, 2023; if accepted, extension to Oct 16, 2023.
- No immediate impact on listing or trading of common stock on Nasdaq Capital Market.
- Form 12b-25 filed May 16, 2023 citing unreasonable effort to complete financial review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923016136/0001437749-23-016136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923016136/bkyi20230530_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-016136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer